Several factors have been linked to an increased risk of brain metastases in NSCLC, particularly adenocarcinoma histology, advanced tumor stages, and nodal involvement, as well as EGFR or ALK mutations (among others) and younger age [11,12,13,14,15]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.